Annual Report

Overview

The report describes a year of strong commercial growth despite COVID-19, with net sales reaching Rp. 277.40 billion and medical-device sales increasing sharply. The company launched and marketed pandemic-related products including PCR test kits, vitamins, and supplements. It also invested in PYFA Health Singapore Pte. Ltd. and reported CSR expenditure of Rp. 272,545,406 for 2020.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: Ends 31 December 2020
Language: English, Indonesian
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services